PAUL ALGATE,STEPHANIE JANE CLEGG,JENNIFER L. CRAIGEN,PAUL ANDREW HAMBLIN,ALAN PETER LEWIS,PATRICK MAYES,RADHA SHAH PARMAR,TREVOR ANTHONY KENNETH WATTAM
申请号：
US15828770
公开号：
US20180147293A1
申请日:
2017.12.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention concerns antigen binding proteins and fragments thereof which specifically bind B Cell Maturation Antigen (BCMA), particularly human BCMA (hBCMA) and which inhibit the binding of BAFF and APRIL to the BCMA receptor. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
